Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/29/25
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate DevelopmentBusiness Wire • 10/22/25
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification CapabilitiesBusiness Wire • 10/20/25
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and AdoptionBusiness Wire • 10/15/25
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference CallBusiness Wire • 10/14/25
3 Medical Service Industry Stocks Poised to Counter Workforce IssuesZacks Investment Research • 10/10/25
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity TestingBusiness Wire • 10/08/25
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat CancerBusiness Wire • 09/11/25
Charles River Laboratories International, Inc. (CRL) Presents At Baird 2025 Global Healthcare Conference (Transcript)Seeking Alpha • 09/10/25
Charles River Laboratories International, Inc. (CRL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/09/25
Charles River Laboratories to Present at Baird and Morgan Stanley ConferencesBusiness Wire • 09/08/25
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life SciencesBusiness Wire • 09/03/25
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T ManufacturingBusiness Wire • 08/26/25
Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call TranscriptSeeking Alpha • 08/06/25